Open Access

Impact of inflammation and immunotherapy in renal cell carcinoma (Review)

  • Authors:
    • Jian Shi
    • Keshan Wang
    • Zhiyong Xiong
    • Changfei Yuan
    • Cheng Wang
    • Qi Cao
    • Huang Yu
    • Xiangui Meng
    • Kairu Xie
    • Zhixian Cheng
    • Hongmei Yang
    • Ke Chen
    • Xiaoping Zhang
  • View Affiliations

  • Published online on: September 21, 2020     https://doi.org/10.3892/ol.2020.12135
  • Article Number: 272
  • Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Substantial research attention has been directed at exploring the mechanisms and treatment of renal cell carcinoma (RCC). Indeed, the association between inflammation and tumor phenotypes has been at the center of cancer research. Concomitant with research on the inflammation response and inflammatory molecules involved in RCC, new breakthroughs have emerged. A large body of knowledge now shows that treatments targeting inflammation and immunity in RCC provide substantial clinical benefits. Adequate analysis and a better understanding of the mechanisms of inflammatory factors in the occurrence and progression of RCC are highly desirable. Currently, numerous RCC treatments targeted at inflammation and immunotherapy are available. The current review describes in detail the link between inflammation and RCC.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 20 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shi J, Wang K, Xiong Z, Yuan C, Wang C, Cao Q, Yu H, Meng X, Xie K, Cheng Z, Cheng Z, et al: Impact of inflammation and immunotherapy in renal cell carcinoma (Review). Oncol Lett 20: 272, 2020
APA
Shi, J., Wang, K., Xiong, Z., Yuan, C., Wang, C., Cao, Q. ... Zhang, X. (2020). Impact of inflammation and immunotherapy in renal cell carcinoma (Review). Oncology Letters, 20, 272. https://doi.org/10.3892/ol.2020.12135
MLA
Shi, J., Wang, K., Xiong, Z., Yuan, C., Wang, C., Cao, Q., Yu, H., Meng, X., Xie, K., Cheng, Z., Yang, H., Chen, K., Zhang, X."Impact of inflammation and immunotherapy in renal cell carcinoma (Review)". Oncology Letters 20.5 (2020): 272.
Chicago
Shi, J., Wang, K., Xiong, Z., Yuan, C., Wang, C., Cao, Q., Yu, H., Meng, X., Xie, K., Cheng, Z., Yang, H., Chen, K., Zhang, X."Impact of inflammation and immunotherapy in renal cell carcinoma (Review)". Oncology Letters 20, no. 5 (2020): 272. https://doi.org/10.3892/ol.2020.12135